BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38551814)

  • 1. Lead Compound Development of SRC-3 Inhibitors with Improved Pharmacokinetic Properties and Anticancer Efficacy.
    Lu D; Chen J; Qin L; Bijou I; Yi P; Li F; Song X; MacKenzie KR; Yu X; Yang B; Roy Chowdhury S; Korp JD; O'Malley BW; Lonard DM; Wang J
    J Med Chem; 2024 Apr; 67(7):5333-5350. PubMed ID: 38551814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.
    Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; O'Malley BW
    Mol Endocrinol; 2011 Dec; 25(12):2041-53. PubMed ID: 22053001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid receptor coactivator-3 is a pivotal target of gambogic acid in B-cell Non-Hodgkin lymphoma and an inducer of histone H3 deacetylation.
    Zhao Z; Zhang X; Wen L; Yi S; Hu J; Ruan J; Zhao F; Cui G; Fang J; Chen Y
    Eur J Pharmacol; 2016 Oct; 789():46-59. PubMed ID: 27370960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells.
    Gilad Y; Eliaz Y; Yu Y; Dean AM; Han SJ; Qin L; O'Malley BW; Lonard DM
    Commun Biol; 2021 Mar; 4(1):399. PubMed ID: 33767353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitor.
    Yan F; Yu Y; Chow DC; Palzkill T; Madoux F; Hodder P; Chase P; Griffin PR; O'Malley BW; Lonard DM
    PLoS One; 2014; 9(4):e95243. PubMed ID: 24743578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of improved SRC-3 inhibitors as breast cancer therapeutic agents.
    Qin L; Chen J; Lu D; Jain P; Yu Y; Cardenas D; Peng X; Yu X; Xu J; Wang J; O'Malley BW; Lonard DM
    Endocr Relat Cancer; 2021 Aug; 28(10):657-670. PubMed ID: 34310341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3.
    Song X; Chen J; Zhao M; Zhang C; Yu Y; Lonard DM; Chow DC; Palzkill T; Xu J; O'Malley BW; Wang J
    Proc Natl Acad Sci U S A; 2016 May; 113(18):4970-5. PubMed ID: 27084884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer.
    Lee WK; Kim WG; Fozzatti L; Park S; Zhao L; Willingham MC; Lonard D; O'Malley BW; Cheng SY
    Endocr Relat Cancer; 2020 Apr; 27(4):209-220. PubMed ID: 31977311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment.
    Han SJ; Sung N; Wang J; O'Malley BW; Lonard DM
    Breast Cancer Res; 2022 Oct; 24(1):73. PubMed ID: 36316775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SRC-3 has a role in cancer other than as a nuclear receptor coactivator.
    Ma G; Ren Y; Wang K; He J
    Int J Biol Sci; 2011; 7(5):664-72. PubMed ID: 21647249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma.
    Song X; Chen H; Zhang C; Yu Y; Chen Z; Liang H; Van Buren G; McElhany AL; Fisher WE; Lonard DM; O'Malley BW; Wang J
    Cancer Lett; 2019 Feb; 442():310-319. PubMed ID: 30423406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma.
    Liu J; Xie Y; Guo J; Li X; Wang J; Jiang H; Peng Z; Wang J; Wang S; Li Q; Ye L; Zhong Y; Zhang Q; Liu X; Lonard DM; Wang J; O'Malley BW; Liu Z
    Nat Commun; 2021 Feb; 12(1):1022. PubMed ID: 33589584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1).
    Yi P; Wu RC; Sandquist J; Wong J; Tsai SY; Tsai MJ; Means AR; O'Malley BW
    Mol Cell Biol; 2005 Nov; 25(21):9687-99. PubMed ID: 16227615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.
    Tong Z; Li M; Wang W; Mo P; Yu L; Liu K; Ren W; Li W; Zhang H; Xu J; Yu C
    J Biol Chem; 2015 Jul; 290(30):18596-608. PubMed ID: 26082485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
    Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
    Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
    Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and Functional Impacts of ER Coactivator Sequential Recruitment.
    Yi P; Wang Z; Feng Q; Chou CK; Pintilie GD; Shen H; Foulds CE; Fan G; Serysheva I; Ludtke SJ; Schmid MF; Hung MC; Chiu W; O'Malley BW
    Mol Cell; 2017 Sep; 67(5):733-743.e4. PubMed ID: 28844863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.
    Karmakar S; Foster EA; Blackmore JK; Smith CL
    Endocr Relat Cancer; 2011 Feb; 18(1):113-27. PubMed ID: 21059860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation.
    Cai D; Shames DS; Raso MG; Xie Y; Kim YH; Pollack JR; Girard L; Sullivan JP; Gao B; Peyton M; Nanjundan M; Byers L; Heymach J; Mills G; Gazdar AF; Wistuba I; Kodadek T; Minna JD
    Cancer Res; 2010 Aug; 70(16):6477-85. PubMed ID: 20663904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.